Keiichi Masaki

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Thomas Karlas, David Petroff, M. Sasso et al. · Journal of Hepatology · 2016 · 1.2K citations · Full text

Controlled Attenuation Parameter, Clinical Endpoint, Laboratory Medicine +3

Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma

Yohji Honda, Tomoki Kimura, Hiroshi Aikata et al. · Journal of Gastroenterology and Hepatology · 2012 · 97 citations

Highly multiplexed CRISPR‐Cas9‐nuclease and Cas9‐nickase vectors for inactivation of hepatitis B virus

Tetsushi Sakuma, Keiichi Masaki, Hiromi Abe‐Chayama et al. · Genes to Cells · 2016 · 67 citations · Full text

Immunology, Clear Hbv Infection, Molecular Biology +17

Utility of controlled attenuation parameter measurement for assessing liver steatosis in <scp>J</scp>apanese patients with chronic liver diseases

Keiichi Masaki, Shintaro Takaki, Hideyuki Hyogo et al. · Hepatology Research · 2013 · 66 citations · Full text

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large‐scale, long‐term cohort study

Yuko Nagaoki, Hiroshi Aikata, Norihito Nakano et al. · Journal of Gastroenterology and Hepatology · 2015 · 60 citations